Cuprina Holdings (Cayman) Limited

CUPR ·Healthcare, Medical Devices, Singapore
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024
Operating Activities
Net Income $-3.6M $-1.1M
Depreciation & Amortization $28.4K $31.0K
Depreciation $28.4K $31.0K
Amortization
Stock-Based Compensation
Net Cash from Operating Activities $-7.1M $-908.6K
Investing Activities
Capital Expenditures $45.3K $16.1K
Business Acquisitions
Net Cash from Investing Activities $-45.3K $-16.1K
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $9.5M $985.8K
Net Change in Cash
Free Cash Flow $-7.1M $-924.7K